Cullinan Associates Inc Schrodinger, Inc. Transaction History

Cullinan Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	SELL	$21.62 - $37.21 $88,642 - $152,561	-4,100 Reduced 18.89%	17,600 $630,000
Q3 2023 Oct 11, 2023	BUY	$27.34 - $55.37 $593,278 - $1.2 Million	21,700 New	21,700 $613,000
Q4 2021 Jan 07, 2022	SELL	$33.38 - $59.25 $1.76 Million - $3.12 Million	-52,700 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$53.75 - $76.55 $3.98 Million - $5.66 Million	-74,000 Reduced 58.41%	52,700 $2.88 Million
Q1 2021 Apr 20, 2021	BUY	$64.61 - $113.09 $368,277 - $644,613	5,700 Added 4.71%	126,700 $9.67 Million
Q4 2020 Jan 14, 2021	BUY	$48.06 - $84.4 $5.82 Million - $10.2 Million	121,000 New	121,000 $9.58 Million

235

60.7M

726K

329K

Ticker SDGR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 62,028,400
Market Cap $1.22B
Description
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences i...

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Cullinan Associates Inc with notifications on news.